Navigation Links
Cynosure Reports Financial Results for the First Quarter of 2011
Date:5/3/2011

n Cellulaze, appeared to have long-lasting benefits in the treatment of cellulite. Significant improvement in cellulite was demonstrated in 68 percent of cases by photographic evaluation and 65 percent with Vectra 3D surface imaging.  
  • International Marketing Clearances: During the first quarter, the company announced the receipt of two key international marketing clearances: Health Canada issued a Medical Device License authorizing the SmoothShapes XV system to be marketed in Canada for the temporary reduction in the appearance of cellulite. In addition, the Korea Food and Drug Administration granted marketing approval for the Smartlipo Triplex™ system, the company's minimally invasive technology for fat removal and skin tightening.

  • Business OutlookDavin concluded, "Our financial position remains strong, and we are encouraged to see continuing top-line momentum.  We are optimistic about the prospects for our business as we begin our European launch of Cellulaze and introduce SmoothShapes XV across our direct distribution channel.  As our markets continue to slowly recover from the lingering effects of the recession, we believe Cynosure is well-positioned with a strong brand and broad suite of innovative products that deliver excellent outcomes for aesthetic patients."  

    First-Quarter Financial Results Conference CallIn conjunction with its first-quarter 2011 financial results, Cynosure will host a conference call for investors and analysts at 9:00 a.m. ET today.  On the call, Michael Davin and Timothy Baker, the company's Executive Vice President and Chief Financial Officer, will discuss the company's financial results and provide a business overview. Those who wish to listen to the conference call webcast should visit the "Investor Relations" section of the company's website at www.cynosure.com.  The live call can also be accessed by d
    '/>"/>

    SOURCE Cynosure, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. Cynosure Launches New Workstation and Technology Innovations at American Academy of Dermatology Annual Meeting
    2. Cynosure Announces Presentations at Upcoming Investor Conferences
    3. Cynosure Reports Second Quarter 2009 Financial Results
    4. Cynosure Reports Third Quarter 2009 Financial Results
    5. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
    6. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
    7. Par Pharmaceutical Reports Second Quarter 2008 Results
    8. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
    9. Pharmos Corporation Reports 2008 Second Quarter Results
    10. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
    11. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/20/2014)... The 6th Annual Arrowhead Personalized ... October 29-30 in San Francisco, CA. This year’s conference ... researchers and clinicians focused on addressing and solving the ... the twelve years since the sequencing of the human ... with pharmacogenetic information in the label and molecular diagnostics ...
    (Date:8/20/2014)... Calif. , Aug. 20, 2014 /PRNewswire-iReach/ -- ... the transformative collaboration between the school,s bioengineering department ... part of the Intel® Software Academic Program, UCSD,s ... sciences and the human body.  ... The study exhibits the work of Dr. ...
    (Date:8/20/2014)... 2014 WriteResult®, a leading provider of ... has expanded its myPROpad™ ePRO tablet with the addition ... of the most widely used and well-respected Patient Reported ... The EQ-5D is used during clinical trials and in ... can be used to demonstrate Health-Related Quality of Life ...
    (Date:8/19/2014)... 2014 One of the major ... an inadequate vascular supply. Nutrient and gas transport ... is critical for successful regeneration and integration into ... deficiencies in vascularization and promote angiogenesis in a ... scaffold design and architecture, and enhancing scaffolds with ...
    Breaking Biology Technology:6th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2EQ-5D™ Assessment Now Available for iPad 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2
    ... (NYSE Amex: CUR ) announced that the ongoing ... in amyotrophic lateral sclerosis (ALS or Lou Gehrig,s disease) was ... http://www.neuralstem.com/neuralstem-in-the-news (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO) The trial ... injections. About Neuralstem ...
    ... N.J., Nov. 13, 2011 Pharmasset, Inc. (Nasdaq: ... Capital Markets 8th Annual Healthcare Conference to be held November ... Schaefer Price, Pharmasset,s President and Chief Executive Officer, will provide ... 3:00 PM (ET). To access a simultaneous webcast ...
    ... Discharge 1-2-3 of Schaumburg, IL has been ... Innovation Awards for their Discharge 1-2-3 Composer™. The ... Theater on Tuesday, November 8, with more than 1400 people ... the Chicago region,s foremost recognition of the most innovative new ...
    Cached Biology Technology:Neuralstem ALS Stem Cell Trial Featured on Fox Atlanta 2Pharmasset to Present at the Lazard Capital Markets Healthcare Conference 2Pharmasset to Present at the Lazard Capital Markets Healthcare Conference 3Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award 2Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award 3
    (Date:8/20/2014)... State University, the Wellcome Trust Sanger Institute and the ... Mycobacterium pinnipedii from skeletons found in Peru ... is a relative of the TB bacterium that affects ... These researchers assume that seals carried the pathogens from ... lions was unexpected" comments Sebastien Gagneux, from the Swiss ...
    (Date:8/20/2014)... Research UK scientists have discovered that acral melanomas the ... Marley,s death are genetically distinct from other more common ... external) published in the journal Pigment Cell & Melanoma ... of the hands, soles of the feet, nail-beds and other ... of melanoma, it,s not caused by UV damage from the ...
    (Date:8/20/2014)... could one day be made out of cocoa, rice ... reporting. The novel process they developed and their results, ... and plastic waste problems, appear in the ACS journal ... and colleagues at the Italian Institute of Technology point ... its production reached 288 million tons worldwide, but its ...
    Breaking Biology News(10 mins):Scientists learn more about rare skin cancer that killed Bob Marley 2
    ... Leuven, Belgium - When a blood vessel clogs up, a ... die. However, working with mice, VIB scientists connected to the ... with severe hypoxia from dying. The muscles seem to adapt ... force that animals also use when hibernating, but that has ...
    ... critical difference between flu viruses that infect birds and humans, ... avian flu strains and aid in the development of vaccines ... a virus,s ability to infect humans depends on whether it ... surface of human respiratory cells. Now that we know ...
    ... in marine biomedical laboratories at Scripps Institution of Oceanography ... information about the fundamental biological processes inside a marine ... to treat cancer in humans. The finding could lead ... human diseases. A research team led by Bradley ...
    Cached Biology News:Medical breakthrough for organ transplants and cardiovascular diseases by Flemish researchers 2MIT finds key to avian flu in humans 2MIT finds key to avian flu in humans 3Researchers uncover key trigger for potent cancer-fighting marine product 2
    Rac 1/2/3/4 (S-18)...
    ... Recognizes K+ Cl- ... shows no significant sequence ... or CCC.,SPECIES REACTIVITIES: The ... conserved in human, mouse, ...
    Anti-G-alpha-i 1 G-Protein Host: mouse monoclonal Species Reactivity: human, mouse, rat Applications: WB Storage: 4C...
    Mouse monoclonal [DAPK-55] to DAP Kinase 1 ( Abpromise for all tested applications). entrezGeneID: 1612 SwissProtID: P53355...
    Biology Products: